Literature DB >> 18363883

Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma.

Vítor Trovisco, Joana Pinto Couto, José Cameselle-Teijeiro, Inês Vieira de Castro, Elsa Fonseca, Paula Soares, Manuel Sobrinho-Simões.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18363883     DOI： 10.1111/j.1365-2265.2008.03243.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  8 in total

1.  TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma.

Authors:  Gustavo C Penna; Ana Pestana; José Manuel Cameselle; Denise Momesso; Fernanda Accioly de Andrade; Ana Paula Aguiar Vidal; Mario Lucio Araujo Junior; Miguel Melo; Priscila Valverde Fernandes; Rossana Corbo; Mario Vaisman; Manuel Sobrinho-Simões; Paula Soares; Fernanda Vaisman
Journal:  Endocrine       Date:  2018-06-15       Impact factor: 3.633

2.  BRAFV600E Mutation: Has It a Role in Cervical Lymph Node Metastasis of Papillary Thyroid Cancer?

Authors:  Neslihan Kurtulmus; Burak Ertas; Yesim Saglican; Hakan Kaya; Umit Ince; Mete Duren
Journal:  Eur Thyroid J       Date:  2016-08-20

3.  The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.

Authors:  Catarina Eloy; Joana Santos; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2011-07-28       Impact factor: 4.064

4.  A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma.

Authors:  Simion Chiosea; Marina Nikiforova; Hui Zuo; Jennifer Ogilvie; Manoj Gandhi; Raja R Seethala; N Paul Ohori; Yuri Nikiforov
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

5.  Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patients.

Authors:  Uiju Cho; Woo Jin Oh; Ja Seong Bae; Sohee Lee; Young Sub Lee; Gyeong Sin Park; Youn Soo Lee; Chan Kwon Jung
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

6.  Detection of plasma BRAF(V600E) mutation is associated with lung metastasis in papillary thyroid carcinomas.

Authors:  Bo Hyun Kim; In Joo Kim; Byung Joo Lee; Jin Choon Lee; In Suk Kim; Seong-Jang Kim; Won Jin Kim; Yun Kyung Jeon; Sang Soo Kim; Yong Ki Kim
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

7.  Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.

Authors:  Danuta Gąsior-Perczak; Artur Kowalik; Agnieszka Walczyk; Monika Siołek; Krzysztof Gruszczyński; Iwona Pałyga; Estera Mikina; Tomasz Trybek; Janusz Kopczyński; Ryszard Mężyk; Stanisław Góźdź; Aldona Kowalska
Journal:  Cancers (Basel)       Date:  2019-11-07       Impact factor: 6.639

8.  BRAF V600E and lymph node metastases in papillary thyroid cancer.

Authors:  Pan Chen; Liqin Pan; Wensi Huang; Huijuan Feng; Wei Ouyang; Juqing Wu; Jing Wang; Yuying Deng; Jiaxin Luo; Yanying Chen
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.